Los puntos clave no están disponibles para este artículo en este momento.
and 2014, compared with 25.1% (89 of 354) and 39.5% (879 of 2225) for general payments, respectively. Receipt of research payments was associated with increased prescribing for mRCC but not CML. Similarly, when treating payments as a continuous variable, increasing amounts of general payments were associated with increased prescribing.
Windover et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: